Amanote Research
Register
Sign In
Double‐hit Lymphoma: So What?
Hematological Oncology
- United Kingdom
doi 10.1002/hon.2581
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Cancer Research
Oncology
Hematology
Date
June 1, 2019
Authors
Andrew Davies
Publisher
Wiley
Related search
Drug Therapy for Double-Hit Lymphoma
Drugs in Context
Molecular Medicine
Pharmacology
Double Hit and Double Expressors in Lymphoma: Definition and Treatment
Cancer
Cancer Research
Oncology
The Double Hit Signature Identifies Double-Hit Diffuse Large B-Cell Lymphoma With Genetic Events Cryptic to FISH
Blood
Biochemistry
Immunology
Cell Biology
Hematology
PLK1: A Promising and Previously Unexplored Target in Double-Hit Lymphoma
Journal of Clinical Investigation
Medicine
Transformation of Double-Hit Large B-Cell Lymphoma Into B-Lymphoblastic Lymphoma: A Case Report
Journal of Hematopathology
Forensic Medicine
Pathology
Hematology
Histology
“Triple-Triple” Hit Lymphoma
Case Reports in Internal Medicine
Cryptic Myc and Bcl2 Rearrangements Are Among a Range of Genetic Mechanisms Underlying the Double Hit Signature in Non-Double Hit Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Double-Hit B-Cell Lymphomas
Blood
Biochemistry
Immunology
Cell Biology
Hematology
HIV Takes Double Hit Before Entry
BMC Biology
Developmental Biology
Evolution
Ecology
Genetics
Cell Biology
Molecular Biology
Biochemistry
Biological Sciences
Systematics
Structural Biology
Plant Science
Behavior
Biotechnology
Agricultural
Physiology